Seema Thakore Meloni
Overview
Explore the profile of Seema Thakore Meloni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balogun M, Meloni S, Igwilo U, Roberts A, Okafor I, Sekoni A, et al.
PLoS One
. 2019 Jul;
14(7):e0219903.
PMID: 31344057
Background: Loss to follow-up (LTFU) is a term used to classify patients no longer being seen in a clinical care program, including HIV treatment programs. It is unclear if these...
2.
Balogun M, Sekoni A, Meloni S, Odukoya O, Onajole A, Longe-Peters O, et al.
Pan Afr Med J
. 2019 Jun;
32:60.
PMID: 31223352
Introduction: Nigeria is among six countries responsible for the majority of tuberculosis (TB) cases in the world. The Nigerian government has emphasized community-based case finding to increase detection of TB....
3.
Chang C, Meloni S, Eisen G, Chaplin B, Akande P, Okonkwo P, et al.
Open Forum Infect Dis
. 2015 Nov;
2(4):ofv154.
PMID: 26613097
Background. Despite the benefits of antiretroviral therapy (ART), tuberculosis (TB) is the leading cause of mortality among human immunodeficiency virus (HIV)-infected persons in Africa. Nigeria bears the highest TB burden...
4.
Meloni S, Chang C, Chaplin B, Rawizza H, Jolayemi O, Banigbe B, et al.
Open Forum Infect Dis
. 2015 Mar;
1(2):ofu055.
PMID: 25734125
Background: Most evaluations of loss to follow-up (LTFU) in human immunodeficiency virus (HIV) treatment programs focus on baseline predictors, prior to antiretroviral therapy (ART) initiation. As risk of LTFU is...
5.
Balogun M, Sekoni A, Meloni S, Odukoya O, Onajole A, Longe-Peters O, et al.
Am J Trop Med Hyg
. 2014 Dec;
92(3):625-32.
PMID: 25510722
Nigeria has the world's 10th largest tuberculosis (TB) burden. Targeted community-based interventions can potentially help reduce TB incidence. We designed an intervention in a periurban community where 10 community volunteers...
6.
Hamel D, Sankale J, Eisen G, Meloni S, Mullins C, Gueye-Ndiaye A, et al.
AIDS Res Hum Retroviruses
. 2007 Oct;
23(10):1189-96.
PMID: 17961103
Over a 20-year period we have observed the dynamics of HIV-1 subtypes and HIV-2 infection in a prospective cohort of registered female sex workers (FSW) in Dakar, Senegal. Prevalence and...
7.
Sankale J, Langevin S, Odaibo G, Meloni S, Ojesina A, Olaleye D, et al.
AIDS Res Hum Retroviruses
. 2007 Aug;
23(8):1020-5.
PMID: 17725419
Multiple HIV-1 subtypes and circulating recombinant forms (CRFs) are known to circulate in West Africa. We undertook a survey of HIVs in Oyo state, in southwestern Nigeria. We analyzed 71...
8.
MacNeil A, Sarr A, Sankale J, Meloni S, Mboup S, Kanki P
J Virol
. 2007 Mar;
81(10):5325-30.
PMID: 17329334
Studies have shown that human immunodeficiency virus type 2 (HIV-2) is less pathogenic than HIV-1, with a lower rate of disease progression. Similarly, plasma viral loads are lower in HIV-2...
9.
MacNeil A, Sankale J, Meloni S, Sarr A, Mboup S, Kanki P
J Infect Dis
. 2007 Jan;
195(5):726-33.
PMID: 17262716
Background. Disease progression and transmission of human immunodeficiency virus (HIV) type 2 are attenuated, compared with HIV-1, which is consistent with the lower plasma viral loads observed in HIV-2 infection....
10.
MacNeil A, Sankale J, Meloni S, Sarr A, Mboup S, Kanki P
J Virol
. 2006 Jul;
80(15):7316-21.
PMID: 16840312
Retroviruses have distinct preferences in integration site selection in the host cell genome during in vitro infection, with human immunodeficiency virus type 1 (HIV-1) integration strongly favoring transcriptional units. Additionally,...